Researches on manipulating pluripotent stem cells derived from blastocysts or primordial germ cells (PGCs) have a great advantage for developing innovative technologies in various fields of life science including medicine, pharmaceutics, and
biotechnology. Since their first isolation in the mouse embryos(1), stem cells or stem cell-like colonies have been continuously established in the mouse of different strains(21), cattle(2, 3), pig(4, 5), rabbit(6, 7), and human(9). However,
full-term
development originated from established pluripotent cells, which is an absolute criterion for proving cell pluripotency and differentiation, has only been reported in the mouse(22). Due to technical difficulties, no further progress has been made
in the
establishment of animal embryonic stem (ES) cell line. Alternatively, the use of embryonic germ (EG) cells was selected to establish an animal stem cell line. EG cells also have pluripotent characteristics, which were proven by morphological
assay,
intracellular alkaline phosphatase activity, and reactions with cell surface-specific markers. The finding of Labosky et al.(23) on germline chimera development after transfer to embryos clearly proved the pluripotency of EG cells and their
similar
characteristics with ES cells.
Avian transgenesis has an unlimited value in biotechnology industry, since its applicability as a bioreactor has proven to be greater than that of mammalian species(24). In the chicken, EG cells can be extensively utilized instead of ES cells for
efficiently inducing transgenesis mediated by germline transmission. Recently, PGCs collected from the embryonic gonad were suggested to be useful in establishing avian stem cells. Technical feasibility and applicability of gonadal PGCs (gPGCs)
to
germline chimera production were also confirmed(25) and a gPGC culture system to establish EG cells was subsequently developed(15).
|